Pharmaforce Medex Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 9.00 Cr
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.13 M
- Revenue Growth %
- Profit Growth 52.76%
- Ebitda 48.78%
- Net Worth 212.48%
- Total Assets 68.38%
About Pharmaforce Medex
Pharmaforce Medex Private Limited (PMPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 November 2019 (Five years and three months 5 days old ). Its registered office is in Sirmaur, Himachal Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.00 Cr.
The company currently has active open charges totaling ₹4.13 M.
Nikunj Tyagi, Satish Sharma, and Arjun Singh serve as directors at the Company.
Company Details
- Location
Sirmaur, Himachal Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230HP2019PTC007703
- Company No.
007703
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Nov 2019
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Who are the key members and board of directors at Pharmaforce Medex?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satish Sharma  | Director | 16-May-2024 | Current |
| Nikunj Tyagi | Whole-Time Director | 28-Jul-2020 | Current |
| Arjun Singh | Director | 24-Jul-2024 | Current |
Financial Performance of Pharmaforce Medex.
Pharmaforce Medex Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 52.76% increase in profit. The company's net worth Soared by an impressive increase of 212.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmaforce Medex?
In 2022, Pharmaforce Medex had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sirmour Remedies Private LimitedNikunj Tyagi and Arjun Singh are mutual person
Mediforce Healthcare Private LimitedNikunj Tyagi is a mutual person
Mankind Pharma LimitedSatish Sharma is a mutual person
Yvns Momkidsfashion LlpNikunj Tyagi is a mutual person
- Shriom Organics Private Limited
Nikunj Tyagi is a mutual person
- Mediforce Research Private Limited
Nikunj Tyagi and Arjun Singh are mutual person
Charges (Loans)
₹0.41 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 0.41 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Mar 2024 | Others | ₹4.13 M | Open |
How Many Employees Work at Pharmaforce Medex?
Unlock and access historical data on people associated with Pharmaforce Medex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmaforce Medex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmaforce Medex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
